Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.

Tremblay AJ, Lamarche B, Ruel IL, Hogue JC, Deshaies Y, Gagné C, Couture P.

Atherosclerosis. 2006 Sep;188(1):203-12. Epub 2005 Dec 6.

PMID:
16337207
2.

Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hypercholesterolemia carrying the same null LDL receptor gene mutation.

Tremblay AJ, Lamarche B, Ruel I, Hogue JC, Bergeron J, Gagné C, Couture P.

Atherosclerosis. 2004 Feb;172(2):367-73.

PMID:
15019548
3.

Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.

Hogue JC, Lamarche B, Deshaies Y, Tremblay AJ, Bergeron J, Gagné C, Couture P.

Metabolism. 2008 Feb;57(2):246-54. doi: 10.1016/j.metabol.2007.09.008.

PMID:
18191056
4.
5.

Coexisting dysbetalipoproteinemia and familial hypercholesterolemia. Clinical and laboratory observations.

Carmena R, Roy M, Roederer G, Minnich A, Davignon J.

Atherosclerosis. 2000 Jan;148(1):113-24.

PMID:
10580177
6.

Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9.

Ouguerram K, Chetiveaux M, Zair Y, Costet P, Abifadel M, Varret M, Boileau C, Magot T, Krempf M.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1448-53. Epub 2004 May 27.

7.

Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes.

Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ.

Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):2966-74.

8.

Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.

Cummings MH, Watts GF, Umpleby M, Hennessy TR, Quiney JR, Sönksen PH.

Atherosclerosis. 1995 Feb;113(1):79-89.

PMID:
7755658
9.

Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.

Lamon-Fava S, Diffenderfer MR, Barrett PH, Buchsbaum A, Nyaku M, Horvath KV, Asztalos BF, Otokozawa S, Ai M, Matthan NR, Lichtenstein AH, Dolnikowski GG, Schaefer EJ.

Arterioscler Thromb Vasc Biol. 2008 Sep;28(9):1672-8. doi: 10.1161/ATVBAHA.108.164541. Epub 2008 Jun 19.

12.
13.

Effect of fenofibrate on plasma lipoprotein composition and kinetics in patients with complete hepatic lipase deficiency.

Ruel IL, Lamarche B, Mauger JF, Badellino KO, Cohn JS, Marcil M, Couture P.

Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2600-7. Epub 2005 Oct 13.

14.

Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction.

Hopkins PN, Wu LL, Schumacher MC, Emi M, Hegele RM, Hunt SC, Lalouel JM, Williams RR.

Arterioscler Thromb. 1991 Sep-Oct;11(5):1137-46.

15.

Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.

Hooper AJ, Heeks L, Robertson K, Champain D, Hua J, Song S, Parhofer KG, Barrett PH, van Bockxmeer FM, Burnett JR.

J Clin Endocrinol Metab. 2015 Nov;100(11):E1484-90. doi: 10.1210/jc.2015-2731. Epub 2015 Aug 31.

PMID:
26323024
16.

Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.

Watts GF, Barrett PH, Ji J, Serone AP, Chan DC, Croft KD, Loehrer F, Johnson AG.

Diabetes. 2003 Mar;52(3):803-11.

17.

Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.

Gaffney D, Forster L, Caslake MJ, Bedford D, Stewart JP, Stewart G, Wieringa G, Dominiczak M, Miller JP, Packard CJ.

Atherosclerosis. 2002 May;162(1):33-43.

PMID:
11947895
18.
19.

Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.

Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ.

Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1703-7. Epub 2004 Jul 8.

20.

Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation.

Tremblay AJ, Lamarche B, Ruel IL, Hogue JC, Bergeron J, Gagné C, Couture P.

J Lipid Res. 2004 May;45(5):866-72. Epub 2004 Feb 16.

Items per page

Supplemental Content

Write to the Help Desk